Six strong recommendations developed, including initial management of dietary modifications and ensuring adequate fluid, fiber intake ...

Weight reduction at one year linked to medication active agent, dosage, treatment indication, persistence of coverage ...

Liraglutide results in greater reduction in BMI than placebo plus lifestyle intervention for children with obesity ...

The Epitomee capsule is a self-administered medical device that once ingested, expands in the stomach and occupies the space creating a sensation of fullness.

(HealthDay News) — A lot of Americans are on the fence regarding annual flu and COVID shots, a new survey finds. More than one-third of those polled (37%) said they’d gotten vaccines in the past but ...

The Food and Drug Administration (FDA) has approved Ebglyss™ (lebrikizumab-lbkz) for the treatment of adult and pediatric patients aged 12 years and older who weigh at least 40kg with moderate to ...

Lifetime use of standard statin increased QALYs by 0.24 to 0.70, with further increase seen for higher-intensity statins.

A New Drug Application will be submitted to the Food and Drug Administration based on these results. Top-line results were announced from a phase 3 trial evaluating nerandomilast an oral, ...

The approval in adolescent patients was based on evidence from the phase 3 SINUS-24 and SINUS-52 trials. The Food and Drug Administration (FDA) has expanded the approval of Dupixent ® (dupilumab ...

HealthDay News — Statistics from 2023 on US obesity rates reveal that in every US state, 1 in every 5 people now has obesity, according to data released Thursday by the US Centers for Disease Control ...

The Food and Drug Administration (FDA) has approved Tecentriq Hybreza ™ (atezolizumab and hyaluronidase-tqjs) for subcutaneous (SC) injection, for all the approved indications of intravenous ...